| Literature DB >> 30209188 |
Yuko Okuyama1,2,3, Yuki Tanaka4,5, Jing-Jing Jiang1,2,3,4,5, Daisuke Kamimura6,2,3,4,5, Akihiro Nakamura1,2,3, Mitsutoshi Ota4,5, Takuto Ohki4,5, Daisuke Higo7, Hideki Ogura1,2,3,4,5, Naoto Ishii8, Toru Atsumi1,2,3,4,5, Masaaki Murakami6,2,3,4,5.
Abstract
Bmi1 is a polycomb group protein and regulator that stabilizes the ubiquitination complex PRC1 in the nucleus with no evidently direct link to the NF-κB pathway. In this study, we report a novel function of Bmi1: its regulation of IκBα ubiquitination in the cytoplasm. A deficiency of Bmi1 inhibited NF-κB-mediated gene expression in vitro and a NF-κB-mediated mouse model of arthritis in vivo. Mechanistic analysis showed that Bmi1 associated with the SCF ubiquitination complex via its N terminus and with phosphorylation by an IKKα/β-dependent pathway, leading to the ubiquitination of IκBα. These effects on NF-κB-related inflammation suggest Bmi1 in the SCF complex is a potential therapeutic target for various diseases and disorders, including autoimmune diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30209188 DOI: 10.4049/jimmunol.1701223
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422